ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000719.1|Tobramycin_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.722	8024	9736	+	Loose	n/a	0.664829	adeH	28.0	ARO:3000779	adeH	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	920	28.8758	28.8758	ATGCGTGTCCTCGGACTGAACGGCTGGCCCCGCGACTTCCACGACGCGTCGGCGGCCCTGCTCGTCGACGGCCGGATCACGGCGTTCGCCGAGGAGGAGCGGTTCACCAGGAAGAAGCACGGGTACGACACGGCTCCCGCGCAGGCGGCGGCGTTCTGCCTGGCCCAGGCGGGCCTGACCGTGGACGACCTGGACGCCGTGGCCTTCGGCTGGGACCTGCCCAGGATGTACCGCGAGCGGCTGGGCGGCTGGCCGCACTCGGACAGCGAGGCGCTGGACATCCTGTTGCCCCGGCACCTCTTCCCCCGGCGCACCGACCCGCCGCTGCACTTCGTCCAGCACCACGTGGCGCACGCGGCCAGCGCCTACCACTTCTCCGGCGTCGACCACGGCGCGGTGCTGATCGTGGACGGCGAGGGCGAGGAGGAGTGCGTCACCCTGGCCCGGGCCGAGGGCGGGAAGATCACCGTGCTGGACACCGTCCCCGGTGCGTGGTCCCTGGGCTTCTTCTACGAGTCGGTCAGCGAGTACACCGGCCTGGGCGGCGAGAACCCCGGCAAGCTCATGGGACTGGCCGCGCACGGGACCGCGGCGGACGAGACGATGTCCACCTTCGCCTTCGAGCCGGACGGTTACCGGCTCGGCCTGCTCGACCCGGACGCGCGGGACCCGGAGGACTGGGACGAGTACTACCTGACGCAGCGGGCGTGGTTCGCGCACCTGGAGCGGACGTATCGCTTGCCCCCCAACGAGTTCGTCCACCGCTACGACCCCGCCAAGGGGCGGGTCGTGCGGGACACGCGACGGGACCCCTACGAGTACCGGGATCTGGCGGCCACCGCCCAGGCGGCGTTGGAGCGCGCGGTGTTCGGGCTGGCCGACTCGGTGCTCTCCCGCACGGGAGAGCGCAGTCTGTTCGTCGCAGGCGGTGTCGGTCTCAACGCGACCCTGAACGGCAAGCTGCTGACGCGGTCCACTGTGGACCACGTGTTCGTTCCCCCGGTGGCCAGCGACATCGGCGTGAGCCTCGGCGCGGCGGCGGTGGTCGCCGTCGAGCTCGGCGACCGCATCGCGCCCATGGGCGACACCGCCGCCTGGGGACCGGAGTTCTCCCCGGACCACGTGCGGGCCGCGCTCGACCGCACCGGCCTGTCCTACCGGGAGCCGGCCAACCTGGAGCGGGAGGTCGCCACGCTCGTCGCCGACGGCAAGGTGGTGGGCTGGGCGCAGGGCAGGGCCGAGGTCGGCCCGAGGGCGTTGGGCCAGCGCAGCCTGCTGGGCTCCGCGCACTCCCCGACCATGCGCGACCACATCAACCTGCGGGTCAAGGACCGGGAGTGGTGGCGTCCGTTCGCCCCCAGCATGCTGCGCTCGGTCAGCGACCAGGTGCTGGAGGTCGACGCCGACTTCCCCTACATGATCATGACGACGAAGGTGCGCGCGGCCTACGCCGAGCGCCTGCCGTCGGTGGTGCACGAGGACTGGTCGACCCGCCCGCAGACCGTGACCGAGGCCGGGAACCCGCGCTACCACCGGATGCTCACCGAGCTCGGCGACCTGGTCGGCGACCCGGTCTGCCTCAACACCTCCTTCAACGACCGGGGCGAACCCATCGTCTCGTCGCCGGCCGACGCCCTGCTCACCTTCGCCCGCCTGCCGATCGACGCCCTGGCCGTCGGCCCGTACCTGGTGACCAGGGACCTCCGCCACTAG	MRVLGLNGWPRDFHDASAALLVDGRITAFAEEERFTRKKHGYDTAPAQAAAFCLAQAGLTVDDLDAVAFGWDLPRMYRERLGGWPHSDSEALDILLPRHLFPRRTDPPLHFVQHHVAHAASAYHFSGVDHGAVLIVDGEGEEECVTLARAEGGKITVLDTVPGAWSLGFFYESVSEYTGLGGENPGKLMGLAAHGTAADETMSTFAFEPDGYRLGLLDPDARDPEDWDEYYLTQRAWFAHLERTYRLPPNEFVHRYDPAKGRVVRDTRRDPYEYRDLAATAQAALERAVFGLADSVLSRTGERSLFVAGGVGLNATLNGKLLTRSTVDHVFVPPVASDIGVSLGAAAVVAVELGDRIAPMGDTAAWGPEFSPDHVRAALDRTGLSYREPANLEREVATLVADGKVVGWAQGRAEVGPRALGQRSLLGSAHSPTMRDHINLRVKDREWWRPFAPSMLRSVSDQVLEVDADFPYMIMTTKVRAAYAERLPSVVHEDWSTRPQTVTEAGNPRYHRMLTELGDLVGDPVCLNTSFNDRGEPIVSSPADALLTFARLPIDALAVGPYLVTRDLRH	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	BGC0000719.1|Tobramycin_6#8025#9737#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.722	gnl|BL_ORD_ID|304|hsp_num:0	542
BGC0000719.1|Tobramycin_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.728	2522	3622	+	Loose	n/a	1.58731	tet36	47.62	ARO:3000197, ARO:3000197, ARO:3002819, ARO:3000808, ARO:3002639	tet36, APH(3'')-Ib, msrC, MexI	protein homolog model	n/a	antibiotic target protection protein; determinant of tetracycline resistance	antibiotic inactivation enzyme; antibiotic target protection protein; determinant of aminoglycoside resistance; determinant of tetracycline resistance; efflux pump complex or subunit conferring antibiotic resistance	500	26.9498	26.9498, 26.5646, 26.9498, 26.1794, 24.6386	ATGTTTGGCGACGCGACCCTGCCCCTCGCTCCCGTCGCCACGCGTCCTTTGGTGTGCACGCCAGGACTTGGGGGTCGTCGCGTGAAGGCACTGACGTTCGTAGCGCCCGGCGAGGCGGTCTTCGGCACCCGCGCGGTGCCCGTCCCCGCCCCCGGTGAGGCGCTGGTCCGCCTCGGGTACAACTCGATCTGCGGCAGCGACCTGTCGCTGTACCGGGGCGTCTGGCACGGATTCGGCTACCCGGTCGTGCCGGGTCACGAGTGGAGCGGGACGGTCGTCGAGGTCAACGGGCCCGGCGACGAGTTGGTCGGCCGGGACGTGGTCGGCGACCTCACGTGCCCGTGCGGCGCGTGTGCCGCCTGTCAGCGCGGGACTCCGGTGCTCTGCGAGAACCTCCAGGAACTCGGGTTCACCCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCGACGCGCAACCTGCACCGGCTGCCGGCGGAACTGTCGTTGCGGGTCGCCTGCCAGGTGGAGCCGGTCGCCGTTGCCCTGCACGCTCTGTCCACTGTGGACGTCTCGCCCGGGGAGAAGGTGGCCGTCCTCGGCGCCGGCGGGATCGGCCTGCTGTTGTCACAGGTGGCGCGACACCGGGGCGCGGTGATCACCACCGTCGGCGAGCCCGTCCCCGAGCGCAGGGCGGTCGCCGCCCAGCTCGGGGCGGCGACGGTGACGACCGGCCGCCCCGGCGAGCTGGCGGACCTGGTGGCCAAACGCCCGGAGCTGACCCCCGACGTCGTGCTGGAGGCCTCCGGCTACCCGGTCGCCCTGCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGCGTGGTGGGCTACCGGGTCGAGGAGATCAGCCCGATGGCGACCCACCACGTCGCCGTGAAGGCGTTGACGATCCGGGGCTCGCTGGGGCCCGGCAACCGGTTCCCCGACGCCATCGACCTGCTCGCTCGGCGCGAGATCAACGTCGATCCGCTGCTCAGCCACGAGTTCGCGCTGGCCGACCACGCCCGCGCGCTGGAGCTCGCGTTGCGCCGCACCGAGGGCAACATCCGCTCGTTCTTCAACCTCCGCGCCTGA	MFGDATLPLAPVATRPLVCTPGLGGRRVKALTFVAPGEAVFGTRAVPVPAPGEALVRLGYNSICGSDLSLYRGVWHGFGYPVVPGHEWSGTVVEVNGPGDELVGRDVVGDLTCPCGACAACQRGTPVLCENLQELGFTRDGACAEYMTIPTRNLHRLPAELSLRVACQVEPVAVALHALSTVDVSPGEKVAVLGAGGIGLLLSQVARHRGAVITTVGEPVPERRAVAAQLGAATVTTGRPGELADLVAKRPELTPDVVLEASGYPVALQEAIEVVRPGGRIGVVGYRVEEISPMATHHVAVKALTIRGSLGPGNRFPDAIDLLARREINVDPLLSHEFALADHARALELALRRTEGNIRSFFNLRA	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	BGC0000719.1|Tobramycin_2#2523#3623#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.728	gnl|BL_ORD_ID|596|hsp_num:0	1708
BGC0000719.1|Tobramycin_4	ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	5207	6394	+	Loose	n/a	2.19843e-18	patA	26.99	ARO:3000024, ARO:3002569, ARO:3000275, ARO:3002571, ARO:3002836	patA, AAC(6')-Iaa, AAC(6')-Iy, linB, lnuB	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic inactivation enzyme; determinant of aminoglycoside resistance; determinant of lincosamide resistance; efflux pump complex or subunit conferring antibiotic resistance	500	82.8037	82.8037, 25.409, 24.6386, 25.7942, 24.6386	ATGACCCAGACCAACGAGATCAGCGCGACGACGGGGGACTGGAGCCGGTCCGCCGAGCACCTGCGCCGGTCCCACGAGGTCACCACCAACCCCCGTCCCGACCAGGACGGCCAGTTCCCCTGCGTGCTCTCCAGGGGCGCGGGGGCGCGCGTGTACGACCTGGACGACAACGCCTACTTCGACCTCACCTGCTCGTTCGGCACCGTCCTCATCGGACACGCCGAGCCGGCCGTCACCGACGCGATCCGGGCGAGCCTGGACGACGGGAACCTGTTCTACACCGGGCCGAGCCCGCGCCGGCTCGCGCTGGCCGAACGCCTGCTCGACTGGTTCCCCTGGGCCGACCAGGCGTTGTTCTACCGGACCGGGTCCTGCGCGGTCTCCGCGGTCGCCCGGCTCACCCAGCACGTCACCGGCCGGACGACCGTGCTCACCTCGGGCTACCACGGCTGGCATGACTGGCACCTGGAGGCGGTGCCGGAGGCCAAGCTGTTCCCGTCCTACGCCACCGAGTTCCACGAGGACCTCGACGTCTACCGCGCCTACCTGGAGCGGCACGCGGACGAGATCGCCGCCGTGGTCGTCACGCCGGAGCCCACGCGGAAACCGGTGGGCCACTACCGCGTTCTGCGCGAGCTGGCCGCCGAGCACGGCTGTCTGTTCGTGGTGGACGAGGTGAAGACGGGCATGCGCGCGGGGAAGGGCGGGCTCAGCGCCCTCGCCGGGCTGGAACCGGACGCGGTGACCGTCTCCAAGGGACTGGCCAACGGGCACAGCATCTCCGCCGTGGTGGGCAGCCGCCGGATCACCGACGGCCTCGACGAGGCCCACGTGTGGTCCACGTACCAGAACGAGCAGGTGGGCTTCGCCGCCGCACTGGCCACTGTGGACTTCCTGGAGAGCCAGGACGTGGCCGCGGTCGTCGGACGCACGGGACGCGTGGTGGAGCAGGCGTTCCGGAGCGCGTTCGCCGAACGGGGCCTCCCGGTGGAGGTGCGCGGCTGGGGCCCGATGTTCGACCTCGACTTCTCCGCTGCCGAGGAGGGACTGGCCGACCGCCTGCAACTCGCCTTCCTCCGCCACGGCGTCTTCTGCGACATCGGCGACGACTTCAACGTCATGTACCGCACCGCCGACCACCTCGACGAGCTGACCGGGCGGGTGACCGCGGCGATCAGGTCGGTCTGA	MTQTNEISATTGDWSRSAEHLRRSHEVTTNPRPDQDGQFPCVLSRGAGARVYDLDDNAYFDLTCSFGTVLIGHAEPAVTDAIRASLDDGNLFYTGPSPRRLALAERLLDWFPWADQALFYRTGSCAVSAVARLTQHVTGRTTVLTSGYHGWHDWHLEAVPEAKLFPSYATEFHEDLDVYRAYLERHADEIAAVVVTPEPTRKPVGHYRVLRELAAEHGCLFVVDEVKTGMRAGKGGLSALAGLEPDAVTVSKGLANGHSISAVVGSRRITDGLDEAHVWSTYQNEQVGFAAALATVDFLESQDVAAVVGRTGRVVEQAFRSAFAERGLPVEVRGWGPMFDLDFSAAEEGLADRLQLAFLRHGVFCDIGDDFNVMYRTADHLDELTGRVTAAIRSV	MNRLPSSASALACSAHALNLIEKRTLDHEEMKALNREVIEYFKEHVNPGFLEYRKSVTAGGDYGAVEWQAGSLNTLVDTQGQEFIDCLGGFGIFNVGHRNPVVVSAVQNQLAKQPLHSQELLDPLRAMLAKTLAALTPGKLKYSFFCNSGTESVEAALKLAKAYQSPRGKFTFIATSGAFHGKSLGALSATAKSTFRKPFMPLLPGFRHVPFGNIEAMRTALNECKKTGDDVAAVILEPIQGEGGVILPPPGYLTAVRKLCDEFGALMILDEVQTGMGRTGKMFACEHENVQPDILCLAKALGGGVMPIGATIATEEVFSVLFDNPFLHTTTFGGNPLACAAALATINVLLEQNLPAQAEQKGDMLLDGFRQLAREYPDLVQEARGKGMLMAIEFVDNEIGYNFASEMFRQRVLVAGTLNNAKTIRIEPPLTLTIEQCELVIKAARKALAAMRVSVEEA	BGC0000719.1|Tobramycin_4#5208#6395#1#ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	gnl|BL_ORD_ID|679|hsp_num:0	2081
BGC0000719.1|Tobramycin_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.726	6447	7973	+	Loose	n/a	0.585707	MexY	31.75	ARO:3003033, ARO:3000375	ErmB, MexY	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance	400	28.8758	28.8758, 24.6386	ATGCTGCTGATCTCACCGGACGAGGCCGCGCGTCGGACCTACGACGCCTGTGTCATCGGCAGCGGCGCCTCCGGCTCCGTGGCCGCGGCCGTGCTCGCCGAGCGCGGTCTGTCGGTGCTCGTGGTGGAACAGGGCGGCCCGATCCCGCCGGGCGCCGACGGGGAGGACCACGAGGACCCCGACGGGTGGGCGTTCGCGCGCCGCGACGGGCGCTGGACCCGGGACGGCTACCCGTGGACGGCCATGGCGCTCGGCGGGGGAACCCTGTTCTACGCCGGGATGTCCTACCGCTACCAGCAGACCGACCTGGCCCCGCCCTCGTCGTTCCTCGGCGCCGCCGACTACGACCACTGGCAGGTCGGCCTCGCCGACCTCGAACCGCACTACGAGTGGATCGAGTACCAGCTCGCGATCGCCGGCCCCTCCAGGAAACAGGTGGGCGACTACGTCTTCCCCGTCTACCACCGGCCGAGCCTGCCGCTCACGCCGCCCGGCGCGGCGCTGGCCGAGGGCGCTCGCTCGCTCCACCTCACGCCCCTGCCCACCCCGGTGGCGATCAGCGGGGTGCGGGACCGGTTCGGCCCCGGCTGCGCCCAGACCACCCCGTGCACCTCGTTCTCCTGTCCCACGAAGGCCAAGGCCGACGTCGTCAGCCGGGTTCTCGCTCCCGCCGAGGGAGACGTCTCGGTGGTCGTCCACACCAGAGTCGTCCGGCTCGTGGCGTCGAGTCCGCACCGGGTTGACGCGGTCGAGGTGCTCGACCGCGAGAACGGCACGCGCCTGACCCTGCGCGCCCGTCGATTCCTGTTGGCCGCCAACGCGATCCAGTCCGCCGCGCTGCTGCTCCGGTCGACAACCCGCACCGAGCCGGACGGGATCGGCAACCGGCACGGGCTCGTCGGGCGGCACCTCGCGATGAAGAACAGCGTGTACGTGCGCGGGACCATCCCGCGCAGACTGCCCGGGTACACCCCGTTGCGACACCGGTACTCCAGCGTCTGCGTGTTGGACTTCCTCACCGGAGAAGCGTTTCCCGACGGAATCGGCGGACTGATCCACGAGGCCAACCCGTGGGAGCCCGCCGCCGAGCGGGAGGCGGCCCGCGGCACCCTGTTGCAGGTCGAGTGCCTGGTGGGCGACCGGCCCCAGGCCGAGAACCGGGTTCGGCTGTCCCGGACCCGGGACCGGGACGGCCTTCCCCGCATCGTCATGGACTACCGGCCGCACCCCGCCGACCTCCGGCGCTTGGCCGTGTTGTCCGAGCGCGCCCACGACATCCTCACCAAGGCCGGCGCCGTCGACGTGCGCGAGGTGGACACCGCCTACGAGTTGGGCAGCGCGCACCTGCACGGAACCCTGCGCGCCGGCCGAGACCCCCGCACGTCGGTGACCGACCCGTTCGGCCGCCTGCACGACCACGACAACGTCTGGTCGGTCGACGGCGCCACGTTCCCGTTCGCCGGCAACCCCAATCCCACCCTCACCATCCAGGCCAACGCCCACCGGATCGCGCTCGCGATCGACTGA	MLLISPDEAARRTYDACVIGSGASGSVAAAVLAERGLSVLVVEQGGPIPPGADGEDHEDPDGWAFARRDGRWTRDGYPWTAMALGGGTLFYAGMSYRYQQTDLAPPSSFLGAADYDHWQVGLADLEPHYEWIEYQLAIAGPSRKQVGDYVFPVYHRPSLPLTPPGAALAEGARSLHLTPLPTPVAISGVRDRFGPGCAQTTPCTSFSCPTKAKADVVSRVLAPAEGDVSVVVHTRVVRLVASSPHRVDAVEVLDRENGTRLTLRARRFLLAANAIQSAALLLRSTTRTEPDGIGNRHGLVGRHLAMKNSVYVRGTIPRRLPGYTPLRHRYSSVCVLDFLTGEAFPDGIGGLIHEANPWEPAAEREAARGTLLQVECLVGDRPQAENRVRLSRTRDRDGLPRIVMDYRPHPADLRRLAVLSERAHDILTKAGAVDVREVDTAYELGSAHLHGTLRAGRDPRTSVTDPFGRLHDHDNVWSVDGATFPFAGNPNPTLTIQANAHRIALAID	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	BGC0000719.1|Tobramycin_5#6448#7974#1#ID=1_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.726	gnl|BL_ORD_ID|318|hsp_num:0	1786
BGC0000719.1|Tobramycin_3	ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.745	3732	5030	+	Loose	n/a	0.000200068	tet(40)	33.33	ARO:3000567, ARO:3000566, ARO:3000180, ARO:3001313, ARO:3003033	tet(39), tetA(P), tet(40), facT, MexY	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	determinant of elfamycin resistance; efflux pump complex or subunit conferring antibiotic resistance	2060	39.2762	39.2762, 24.6386, 41.5874, 29.6462, 25.0238	GTGTCTCAGCATGCCGCGTCCGCAGACGAAACATCGGCCGGGGCGCCCGCCGCCGACCCGAGCCCCGAATCCCGGGCGCGGGCCAGGGCGACGGGCCGGCGACTGCGCCTGTTCTTCGGGCTGCACGAGCTGGTCCCGCTCTTCCCGCTCTACCCGCTGCTGTTCGCCGACCACGGGCTGTCCACCGCGGGGATCTCCGGGTTGCTGGCCCTCTGGTCGGTCACGGCCTTCGTCCTGGAGGTGCCCTCCGGGGTCCTGGGCGACATGTTCTCCCGCCGTTGGCTGCTCGCCGTCGGCACCGCCGTGCGGGCCTGCGGTTTCGGCCTGTGGGTGGCTTTCCCGTCGCCGTGGGCCTTCGCCGCCGGGTTCCTGTGCTGGGGCCTGTGCGACGCGCTGACCTCGGGAACGCTGGAGTCGCTGATCTACGACGAGCTGCGCGCGGCCGGCGCGTCCCACCGGTACGCGGCGGTGATGGGCAGCGGCCGGGCGGTGTCCCTGCTCTCCACGCTCACCGCGATGACGTTGGCCGGGCCGGTCTTCGCGCTCGGCGGCTACCCGCTCGTCGGGATGATCAGCCTGGGCAGCGGGCTGGCCTGCGCCGTCGCCGCGCTGCGGTTCTCCGAGCCGCCCCGGGACCAGGTCGGGCGGGAGGACGGCGGGTTGCGTTGGTACGTCGCGACCTTCCGGGCCGGGGTGTCGGAGGTGCGGCGGGACCGGGTGGTGCTGCGCGCGGTGCTCATCGCCGCGTCGCTGCACAGCATGACGGCCATCGACGAGTACTTCCCCATGCTGGCAAGGGCGAACGGCGCGTCGACGACGATGGTTCCGGTGCTGGTGGCCGTGACGGTCGTCTGCGCGGCGGCCGGCAGCGGTCTGGTCGGCAGGACCGCGCACGCCCCGCCCGCCGTGCTGGGCCTCGCCCTGCTGGCCTCGGCCGGGCTGATGGTGGCGGGCGCGCTGAGCGGGCTCCAGGCGGGCATGCTCGCCGTCGGGGTGAGCTTCGGCCTGGTGCAGTGGGCGCTGGTGCTGGCCGACACGCGGTTGCAGGACGCGATCACCGGTCCGGCGCGCGCGACCGTCACCTCGGTCGTCGGGTTCGGCGCCGAGGTGGCCTCGGTCGGCTTCTACCTGGGCGCCGGCGCTCTCTCCACCGTCACCTCCACGTCCGAGCTGTTGGCCTGGTTCGCGGTGCCGCTCGTCCTCATCGCGGTGGCCGCCCCGCGCTGGTTGAGACGGGAACCGCAGCCGCCCGGCGAGGTTCCCCGGGCGCCGGGAGCGGAACCACCGCGGCCTGCCTGA	VSQHAASADETSAGAPAADPSPESRARARATGRRLRLFFGLHELVPLFPLYPLLFADHGLSTAGISGLLALWSVTAFVLEVPSGVLGDMFSRRWLLAVGTAVRACGFGLWVAFPSPWAFAAGFLCWGLCDALTSGTLESLIYDELRAAGASHRYAAVMGSGRAVSLLSTLTAMTLAGPVFALGGYPLVGMISLGSGLACAVAALRFSEPPRDQVGREDGGLRWYVATFRAGVSEVRRDRVVLRAVLIAASLHSMTAIDEYFPMLARANGASTTMVPVLVAVTVVCAAAGSGLVGRTAHAPPAVLGLALLASAGLMVAGALSGLQAGMLAVGVSFGLVQWALVLADTRLQDAITGPARATVTSVVGFGAEVASVGFYLGAGALSTVTSTSELLAWFAVPLVLIAVAAPRWLRREPQPPGEVPRAPGAEPPRPA	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFEIPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	BGC0000719.1|Tobramycin_3#3733#5031#1#ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.745	gnl|BL_ORD_ID|1836|hsp_num:0	945
BGC0000719.1|Tobramycin_7	ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.736	9847	11121	+	Loose	n/a	1.0579	OpmD	34.15	ARO:3000809, ARO:3002705	floR, OpmD	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	750	27.7202	27.7202, 25.7942	ATGCCCGTCCACCTCGCGATCAACAACGGAACCCCGGTGCGCACCCGGCCCTGGCCGGTCTGGCCCCAGCCGGCCCGGGGCGCGCTCGGCGCGCTGGAACGCGTGCTCCACTCCGGACGCTGGGCGATCAGCGGCCCCTACCGGGGCGCCGAGTCGGCCGAGCGCCGCTTCGCCAGGACCTTCGCCGCCTACAACGGGGTCGCGCACTGCGTCCCCGCGGCCAGCGGCACCGCCAGCCTCATGCTCGCGCTGGAAGCCTGCGGCGTTGGCGTCGGCGACGAGGTCATCGCCCCCGGACTGTCCTGGGTGGCCTCGGCCTCCACCATCGTCGGCGTCAACGCCGTCCCGGTCCTCGTCGACATCGACCCCGCGACCCTGTGCCTGGACCCGGCCGCGGTCGAGGCGGCGATCACGCCTGCCACCAGGGCGATCGTCGTCGTGCACCTGTACTCCGCGGTGGCCGACCTGGACGCGCTGCGCGGCGTCGCCGACCGGCACGGCCTGCCGCTGATCGAGGACTGCGCCCAGGCCCACGGCGCCGAACACCGCGGCCGTAAGGTCGGCTCGGTCGGCGACATCGGGACGTTCAGCATGCAGCACAGCAAGGTGCTCACCAGCGGGGAGGGCGGAGCCGCGATCACCGACTCCGCCGCGCTGGCCCGCAGGATGGAACACCTGCGCGCCGACGGCCGCTGCTATCCCGCCGCCGCGCCCGCGCCCGGACACATGGAACTGGTCGAGACCGGGGAGCTGATGGGCAGCAACCGGTGCCTGTCGGAGTTCCAGGCCGCCGTGCTCGTCGAGCAGCTCAGGGAACTCGACGAGCAGAACGCCCTGCGCCGTCGCAACGCCCTGCTGCTCAACGAGCTTCTCGCAGAGCAGGGGCTGCGGCCGCAGGACAGCTCGCCAGGCACCACCAGCCGCACGTACTACGTCTACGCCGCCGCCCTGCCCGACGACGCGCTGACCGACGTCCCGATCGCCGCCGTGACCGGGGCGCTCACCGCCGAGCTGGGCTTCCCGATCTCACCGGCCTACGCGCCACTGCACACCAACCGGCTCTACGCGCCGGCCTCCCGCCGCCGGTTCGCGCTCGGCGACGAGCACGAGAAGCGGATCGACCCCGGCCGGTTCCACCTGCCGGTGTGCGAGCGGCTCACCCGCCGCCTGATCACCTTCCACCACGCCGCGTTGCTCGGCGACGAGTCCGACGTGCGCGACATCGCCACCGCCGTCGCCAAGGTGCTGCGGCACCGCGGGGAGCTGCGGGCTTGA	MPVHLAINNGTPVRTRPWPVWPQPARGALGALERVLHSGRWAISGPYRGAESAERRFARTFAAYNGVAHCVPAASGTASLMLALEACGVGVGDEVIAPGLSWVASASTIVGVNAVPVLVDIDPATLCLDPAAVEAAITPATRAIVVVHLYSAVADLDALRGVADRHGLPLIEDCAQAHGAEHRGRKVGSVGDIGTFSMQHSKVLTSGEGGAAITDSAALARRMEHLRADGRCYPAAAPAPGHMELVETGELMGSNRCLSEFQAAVLVEQLRELDEQNALRRRNALLLNELLAEQGLRPQDSSPGTTSRTYYVYAAALPDDALTDVPIAAVTGALTAELGFPISPAYAPLHTNRLYAPASRRRFALGDEHEKRIDPGRFHLPVCERLTRRLITFHHAALLGDESDVRDIATAVAKVLRHRGELRA	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	BGC0000719.1|Tobramycin_7#9848#11122#1#ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.736	gnl|BL_ORD_ID|1772|hsp_num:0	442
BGC0000719.1|Tobramycin_8	ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.714	11151	12311	+	Loose	n/a	2.84505	ErmS	44.12	ARO:3001304, ARO:3000462, ARO:3000553, ARO:3000379, ARO:3002484	ErmS, LRA-13, OprM, adeR, mgtA	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of beta-lactam resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1200	25.7942	25.7942, 24.2534, 24.2534, 24.2534, 26.9498	ATGCAGACCACCACCATCACCATGGGAGACGTCCACTACCCGTACCGGCTCGGCACCGGCTGCGTCGACGCGGTCGTCGACCGGCTGGGCGAGCTGGGCGCCAGCCACTACCTCGTGCTGTGCGACGCGACCGTCGCCGAGCTGTACGGGAATGACCTCGTCGCACGCCTGAACCGCGCGGCCGGGCCGGCCACCGTCCTGGTGCACCCGGCGGGGGAGGAGCACAAGGGGCTCGGCACGCTGAACACCCTCGCCGACGCCGCTCTCCACGCCGGAGTCGACCGGCGGGGACTGGTCGTCGCGCTGGGCGGCGGTGTCACCGGGAACATCGCCGGTCTGCTCGCCGCCCTGCTGTTCCGCGGGATTCGCCTGGTGCACGTGCCGACCACGGTCGTGGCGATGCTCGACTCGGTGCTGTCGTTGAAACAGGCCGTCAACGCCCAGGTGGGCAAGAACCTCGTCGGCACCTTCTACCCGCCGGTCGAGGTGCTCGCCGACACCGCGGTGCTGAACACCCTGCCGGTCAGGGAGATCCGGTCGGGGCTGTGCGAGGTCGTGAAGAACGCGTTGGCGATCCGGCCCAGCATGATCTCCTTCCTGGCCGCCGAGCTGCGACCCGACGGCCGCTACGCCGACGACGTCCTGCGCTGGATGATCGACGAGAGCATCGCGGCGAAGGCCCAGGTCACCGAGCACGACAAGTACGAGCGGCGGGAGGGCCTGGTCCTGGAGTACGGCCACACCGTCGGCCACGCCCTGGAACACGCCTCGCACGGCGCGGTGTCGCACGGCGCCGGCGTCGGGCTGGGAATGGTCGCCGCCGCCCGGGTTTCGCACCGCCTCGGGCACGTCGACGCCGGTTTCGCGGAGCTGCACCGGGAGTTGGTGAGCAAGGTCGGCGTCGCGACGACCGTGCCGACCAGCGTTCCGCACCAGGAGATCACCTACCGGCTCGGCTTCGACAACAAGCGGGGGTACCAGTCCCTCGCCGCCGACCAGTACGCGATGGTCCTGCTGGAGGGCGCTGGCCAACCGCTGCGCCGCGACGGCCTGCCACTGACACCGGTGCCCAGAGCCCTGGTCGACGAGGTCGTGCGGGAACTGGCCGGTGTCCCGTCGCGCGTCGGCGCGTCCGTCGCCACCGCGGGGGGTGCGTCGTGA	MQTTTITMGDVHYPYRLGTGCVDAVVDRLGELGASHYLVLCDATVAELYGNDLVARLNRAAGPATVLVHPAGEEHKGLGTLNTLADAALHAGVDRRGLVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTFYPPVEVLADTAVLNTLPVREIRSGLCEVVKNALAIRPSMISFLAAELRPDGRYADDVLRWMIDESIAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGAVSHGAGVGLGMVAAARVSHRLGHVDAGFAELHRELVSKVGVATTVPTSVPHQEITYRLGFDNKRGYQSLAADQYAMVLLEGAGQPLRRDGLPLTPVPRALVDEVVRELAGVPSRVGASVATAGGAS	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	BGC0000719.1|Tobramycin_8#11152#12312#1#ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.714	gnl|BL_ORD_ID|2205|hsp_num:0	727
